B. Riley analyst Jeff Van Sinderen downgraded Iteris to Neutral from Buy with a price target of $7.20, down from $8, after the company entered a merger agreement to be acquired by Almaviva for $7.20 per share in an all-cash transaction. The firm anticipates the deal will be completed per the company’s expectations.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITI: